Credit Suisse’s ARS Pharmaceuticals SPRY Stock Holding History

Credit Suisse’s Portfolio SPRY Stock Details SPRY Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$302K	Hold
2023 Q4	$162K	Sell
2023 Q3	$126K	Buy
2023 Q2	$214K	Buy
2022 Q3	–	Sell
2022 Q2	$0	Buy
2021 Q3	–	Sell
2021 Q2	$226K	Buy